Trigg KL et al. recently reviewed how clinical trial site operations adapted during major global pandemics. Their scoping review examined 55 studies across seven different health crises. Most research originated from Europe and the Americas, while Southeast Asia contributed significantly fewer articles. Researchers identified seven core operational themes, including policy, technology, and infrastructure. They found that sustaining research during a pandemic requires massive systemic changes.

Furthermore, the authors reported several persistent challenges. Fragmented infrastructure and regulatory bottlenecks often hindered progress. Consequently, many trial sites struggled with protocol-practice misalignment. Additionally, under-resourced sites faced severe difficulties in maintaining high-quality data collection. However, successful sites implemented proactive strategies. Specifically, they utilized digital infrastructure and cross-trained their staff members.

Strengthening Clinical Trial Site Operations for Future Readiness

The review emphasizes the importance of institutionalizing early site engagement. When investigators participate in protocol development early, trials become more resilient. Moreover, streamlined ethics and contracting processes reduce significant delays. For researchers in India, these lessons are particularly vital. Recent studies show that Indian sites often experience enrollment drops during lockdowns. To combat this, experts suggest investing in decentralized trial components.

Additionally, the study highlighted a gap in using adaptive trial designs. These designs allow for flexible modifications during a study. Using such methods can help sites respond to rapidly changing clinical needs. Therefore, future pandemic preparedness must prioritize workforce capacity and infrastructure. Addressing global inequities will also ensure that all regions can participate in timely research.

Frequently Asked Questions

What are the primary operational challenges for trial sites during a pandemic?

Sites frequently face regulatory bottlenecks, fragmented infrastructure, and protocol-practice misalignment. Additionally, staffing shortages and limited resources can disrupt ongoing data collection and patient monitoring.

How can digital infrastructure support clinical trials?

Digital tools enable decentralized trial activities, such as remote monitoring and electronic data capture. These technologies help maintain trial continuity when travel restrictions or lockdowns prevent in-person visits.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional recommendation. The information provided is based on research available at the time of publication and may change as new data emerges. Readers should consult with qualified healthcare professionals for specific medical concerns. Refer to the latest local and national guidelines for clinical practice.

References

1. Trigg KL et al. Operational strategies among infectious disease clinical trial sites during pandemics: a scoping review. Trials. 2026 Apr 07. doi: 10.1186/s13063-026-09677-5. PMID: 41943131.

2. Chander V et al. Challenges in operationalising clinical trials in India during the COVID-19 pandemic. Lancet Glob Health. 2022 Mar;10(3):e321-e322. doi: 10.1016/S2214-109X(21)00546-5. PMID: 34953516.

3. Rajendran NB et al. Impact of COVID-19 on management of clinical trials and the potential mitigating strategies. Perspect Clin Res. 2022;13(2):85-92. doi: 10.4103/picr.picr_215_21. PMID: 35528023.